
Pyridinic analog of the natural product (−)-spectaline as potential adjuvant for the treatment of central nervous system disorders
2015; Elsevier BV; Volume: 25; Issue: 10 Linguagem: Inglês
10.1016/j.bmcl.2015.02.050
ISSN1464-3405
AutoresMarília Valli, Andresa Heemann Betti, Amanda Danuello, Marcos Pivatto, Fernanda Bossemeyer Centurião, Camila B. Antonio, Stela Maris Kuze Rates, Vanderlan da Silva Bolzani,
Tópico(s)Biological and pharmacological studies of plants
ResumoPreviously we designed a series of pyridinic anticholinesterasic compounds based on molecular hybridization between tacrine and the natural piperidine alkaloid (−)-3-O-acetylspectaline isolated from Senna spectabilis. Based on the information that the cholinergic system has an important role in the treatment of schizophrenia and depression, we herein report the evaluation of a series of pyridinic compounds in animal models for antipsychotic and antidepressant-like activities. Compound 2 decreased the immobility time of mice in the forced swimming test (5 and 10 mg/kg p.o.) and prevented the climbing behavior induced by apomorphine (10 mg/kg, p.o.), without impairing animals locomotor activity.
Referência(s)